chrisvoncsefalvay/vaers-outcomes huggingface dataset:
[After first two doses] sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA ([After first two doses] sore arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A, 013M20A and 014F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced MYALGIA ([After first two doses] sore arm). At the time of the report, MYALGIA ([After first two doses] sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. The patient reported that he did not take any medications to treat his symptoms.   This case was linked to MOD-2021-395653, MOD-2021-395666 (Patient Link).
Can still feel tightness in left shoulder muscle.  For 3 weeks - could not use left arm much due to pain upon use of the arm.  Attempted to work out with 3 lb weights but did not help.
Patient was given juice and water verbalized that she was feeling better.  Able to walk around with no complications.  She had stated she felt like she was going to get a massive headache and her mouth felt weird.  Vitals remained stable as previously documented.
PAIN IN BACK OF ARM IMMEDIATELY AND CONTINUED WITH REDNESS, FEVER AND SWELLING.
Received varivax, SC in left arm, on 11/2/00. Started with rash on 11/11/00, at injection site. Examined on 11/14/00 and had X 4, 2-3mm vesicular lesions on area over the site of injection. No tenderness. Impression: cutaneous varicella.
Pain, redness, warmth, and tenderness at injection site (Left arm); Benadryl 25mg PO Q6 Hours x 24 hours prescribed.
Pt recv vax on 3/10/99; 1 hr post vax pt exp swollen/ hot/ red/ itching vax site x 3 days; tx=Allegra
The morning after the 1st COVID vaccine, patient experienced a sudden onset of feeling clammy, pale and narrowing vision. Near syncopal episode. Resolved after lying down and resting for about 10 minutes.
PT SAID AFTER SHE GOT THE INJECTION SHE STARTED WITH INJECTION SITE PAIN THEN GRADUALLY SHE HAS MUSCLE WEAKNESS ON HER LEGS AND ARMS. IN ADDITION SHE HAS LACK OF COORDINATION
Sore arm; Baseball size reddened area around injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced injection site erythema (Verbatim: Baseball size reddened area around injection site) and pain in arm (Verbatim: Sore arm). The outcome of the injection site erythema was resolved (duration 5 days) and the outcome of the pain in arm was not reported.   It was unknown if the reporter considered the injection site erythema and pain in arm to be related to Arexvy.     It was unknown if the company considered the injection site erythema and pain in arm to be related to Arexvy.   Additional Information: GSK Receipt Date: 23-OCT-2023 The case was received from the patient via (Open field AE monitoring) interactive digital media. The patient had baseball size reddened area around injection site. Reddened area around injection site was for 5 days. The patient's arm was also sore. The patient never had reaction to any vaccines.
% days after 1st vaccine I complained about blurry vision and cognitive issues. About 7 days after 2nd vaccine I was hospitalized for 4 days with stroke like symptoms. It's been 2 years now and I still have many of the same issues such as cognitive problems, fatigue, blurry vision on most days, pins and needles feeling in face and hands, and general joint pain. I had to give my business up and didn't work for over 18 months. Trying to start a newer business with less strain but the eye issues and foggy head is making it a struggle.
Information was received on 14-JUN-2017 regarding a case in litigation concerning a female (age not reported). Medical history, concurrent conditions and concomitant medications were not reported. On or about 08-APR-2014 the patient received a dose of ZOSTAVAX (lot # and dose not specified) as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 26-NOV-2016 the patient was treated by a nurse practitioner for a vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. On or about 12-DEC-2016 she was treated further by another nurse practitioner for worsening symptoms. On or about 09-JAN-2017 the patient was treated by a physician assistant at a medical center, at which time she was diagnosed with post herpetic neuralgia, a chronic condition involving residual nerve pain and damage secondary to shingles.  The patient was prescribed gabapentin and trimethoprim (+) sulfamethoxazole (BACTRIM) for management of her ongoing painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
rapid heartbeat that lasted for half an hour; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heartbeat that lasted for half an hour) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse events).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HEART RATE INCREASED (rapid heartbeat that lasted for half an hour) and HEADACHE (headache). On 10-Feb-2021, HEART RATE INCREASED (rapid heartbeat that lasted for half an hour) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication provided no treatment taken   This case was linked to MOD21-029391 (E2B Linked Report).; Sender's Comments:  MOD21-029391:Duplicate report
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/25/2021 and 4/29/2021. Presented to ED on 8/12/2021 with complaints of dyspnea for 1 week requiring oxygen. Patient was placed on oxygen and eventually required mechanical ventilation. Patient had septic shock and acute kidney injury. Medications administered: dexamethasone, ascorbic acid, ceftriaxone, azithromycin, micafungin, remdesivir, piperacillin/tazobactam, tocilizumab, prednisone, and vancomycin. Patient continued to decompensate and expired at 14:44 on 8/29/2021.
7 days after receiving the vaccine I have developed a red patch that is hot to the touch at the injection site.
Tested positive for Covid; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for Covid) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011JQ0A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19. At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: (Positive) around one week after receiving the 1st shot, the patient tested positive for Covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
pt recv vax as part of the childhood immun series & the day p/vax pt exp a hive-like rash;
Pt has a PMH of COPD and emphysema. Pt started to feel sick 2 days prior to admission with shortness of breath, exacerbation with exertion and lying flat. Pt has a nonproductive cough, wheezing, chills, and generalized weakness. She was found to be COVID positive. Pt was admitted with acute respiratory failure with hypoxia.
PATIENT FELT LIGHTHEADED AND WARM. PATIENT LAYED DOWN AND SYMPTOMS RESOLVED
soreness at the injection site of injection; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 73-year-old female patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   The patient's past medical history included herpes zoster (herpes zoster history) and joint pain. Concurrent medical conditions included immunocompromised (had a heart transplant, and a compromised immune system) and diabetes.   On an unknown date, the patient received Influenza vaccine at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not reported, but the patient was 73 years old at the time of reporting. The patient experienced soreness at the site of injection for couple of days. The reporter consented to follow up. This case has been linked with cases US2019AMR182433 and US2019181795 reported by the same reporter for same patient.
Intense stomach pain, led me to seek treatment in urgent care, sent home with no known cause for pain but pain resolved in approximate 24 hours
10/23/21 vaccination. 12/11/2021 Started to experience hives. I started to break out in my R and L elbow first. I called the doctors office, called in prescription and made appt. My lips were swollen as well from the hives, legs, and back; burning, itching. The doctor prescribed methylprednisolone and Zyrtec for 2 weeks. *I am scared to take another booster
5/4/12 vaccine given; 5/5 chills, fatigue, rash; appt 5/7 - Rx for VALTREX given 1gm 1 PO TID x 7 days. Dx shingles.
his armpit swelled on his left arm; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (his armpit swelled on his left arm), PYREXIA (fever) and MYALGIA (body aches) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced SWELLING (his armpit swelled on his left arm), PYREXIA (fever) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 26-Apr-2021, PYREXIA (fever) and MYALGIA (body aches) had resolved. At the time of the report, SWELLING (his armpit swelled on his left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Confusion, Dizziness, Headache, Myalgia, Arthralgia, Nausea Vomiting, SOB and fatigue  Narrative:
First night, 3 different horrible leg cramps both legs, different sites. By am, both shoulders so sore couldn't raise my arms. Left shoulder hurt more than right. Also, really wierd ache in left side. Had to press in hard over heart, lung, to keep from hurting when walked. Stayed in a chair all day, didn't hurt to breath that way, or the minimal movement to read a book didn't hurt.  Next day, still couldn't raise arms  but didn't hurt as much, ditto with weird pain on left side. By 3rd day, still improving, but still couldn't easily brush hair, fasten hair back. Was 4th before was feeling ok to do normal routine.  Almost gone on 5th day, just twinges...md told me not to get 2nd shot...never had a reaction to one before.
Ten minutes after receive vaccine patient stated he feeling off then began to feel sweaty, nauseated, and the vomited x1, had some tingling in fingers and became pale. Vitals taken at 12:37 Bp 100/60 p 80 respiration 24 oz sat 99.  Pt was calmy to the touch but remained coherent. felt slightly faint but refused to lay on cot. Gave well cloth and by 12:50 color was returning BP was 110/70 p 76 and os sat 99.  Tingling was dissipating from fingers. Color was returning to face and body and less clammy. Remained being observed until 1:10 total of 50+ minutes. Bp 112/72 p 72. o2 sat 99.  Escorted to car with driver. told to relax this afternoon and if any further symptoms arise call MD or go to ER.
Welt the size of golf ball, warm to touch inhibiting range of motion. Lasting beyond 3 days
A pharmacist reported that a 65 year old male received an injection of Pnu-Imune 23 on 10/14/99. On 10/16/99, he was seen by a physician, who dx'd cellulitis and prescribed cephradine.
The day after my vaccination (left arm) my left breast starting hurting. It felt similar to when I was breastfeeding and would have milk engorging, so in the shower under hot water tried to massage the breast and I was able to get some fluid out. But it?s been about a year since I stopped breastfeeding my daughter. The discharge was a very thick cream colored fluid along with an oily clear fluid. It was more than a teaspoon of fluid but less than a tablespoon.  I did not have this occur in my right breast. After I expressed the fluid, the pain went away with only some lingering soreness. More than a week later the left breast finally feels normal.
h/a 22APR93, 23APR93 along w/maculopapular rash cheeks, arms, back, chest (immun given 20APR93);
Headache; Slept a lot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) and HYPERSOMNIA (Slept a lot) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced HEADACHE (Headache) and HYPERSOMNIA (Slept a lot). On 31-Jan-2021, HYPERSOMNIA (Slept a lot) had resolved. On 01-Feb-2021, HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported  Treatment details included Tylenol and pain killer.
Fever with 101.3; Shaking; Chills; Malaise; Extreme fatigue; Body aches; Booster dose; Off label use; This is a spontaneous report from a non-contactable physician, the patient. A 33-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an intramuscular route of administration in the arm left on 29Sep2021 at 10:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus and hypothyroidism on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included influenza vaccine (FLU), pneumococcal vaccine polysacch 23v (PNEUMOVAX); both for an unknown indication on 21Sep2021; levothyroxine (MANUFACTURER UNKNOWN), insulin (MANUFACTURER UNKNOWN) and unspecified probiotics (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration on 18Dec2020 as a single dose for COVID-19 immunisation. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) via an intramuscular route of administration on 08Jan2021 as a single dose for COVID-19 immunisation. The patient previously received azithromycin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 29Sep2021 at 22:00, the patient experienced fever (101.3), shaking, chills, malaise, extreme fatigue and body aches. On the same day at 22:00, the patient underwent body temperature monitoring and result was 101.3 (units not specified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever (101.3), shaking, chills, malaise, extreme fatigue and body aches was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Patient got up after  his 15 minute wait period and went shopping and passed out at self-checkout.   Then he woke up and stumbled over in front of vision center and passed out again.  We call EMS and they believe  his blood sugar was really low because all he had to eat today was a banana for breakfast.
12/2821 presents to ED for "persistent cough, chest pain when coughing, n/v and elevated blood sugars". PMHx of "DM type I, UC on chronic steroids"
On 5/22/22 I woke up with chills, fever, congestion, post nasal drip, cough and it felt like allergies but when I got the chills I felt like I needed to take a test.  Plus I was having headaches for sure.  I took a home COVID-19 test and it was positive the next day after having symptoms and was on the phone with the NP when my positive result came through.  They prescribed me something for my cough and Molnulpiravir as a antiviral.  I felt bad for about a week.
No adverse event; On 10-May-2023, 27 patients received a 0.25 ml booster dose of the bivalent Moderna Covid-19 vaccine instead of the 0.5 ml booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (On 10-May-2023, 27 patients received a 0.25 ml booster dose of the bivalent Moderna Covid-19 vaccine instead of the 0.5 ml booster dose) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 067H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 10-May-2023, the patient experienced UNDERDOSE (On 10-May-2023, 27 patients received a 0.25 ml booster dose of the bivalent Moderna Covid-19 vaccine instead of the 0.5 ml booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (On 10-May-2023, 27 patients received a 0.25 ml booster dose of the bivalent Moderna Covid-19 vaccine instead of the 0.5 ml booster dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (On 10-May-2023, 27 patients received a 0.25 ml booster dose of the bivalent Moderna Covid-19 vaccine instead of the 0.5 ml booster dose).    This case contains information for the 25th patient out of 27 patients as described by the reporter.  No concomitant medication information was reported.  All patients were over the age of 65 years.  The first booster dose of vaccine was administered in the deltoid site.  On 10-May-2023, 27 patients received 0.25 ml booster dose of the Moderna bivalent vaccine instead of the 0.5 ml booster dose.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-723833 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723833:Master case
Patient stated the night after she recieved the vaccine that her arm became red and swollen. It was also sore to the touch. She contacted her physician who told her to wait a few days and if it didn't go down to come to the clinic. It did slowly go away and now patient is free of any swelling or redness. Her doctor believed it to be a "mild reaction" to the vaccine per the patient.
Information has been received from a licensed vocational nurse refers to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with VARIVAX (Merck) which were exposed to a supported temperature excursion (lot#, expiration date, dose and route were unknown). No adverse effects have been reported. Additional information has been requested.
Fever of 102 for two days and on the third day became light headed and passed out.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 3/5/2021 and 3/26/2021. Patient reportedly diagnosed with COVID on 9/23/2021 and received Regeneron 9/28/2021. Patient presented to the emergency department on 10/4/2021 for rapidly progressed malaise. Patient admitted to hospital for altered mental status, dehydration, and COVID pneumonia. Patient received: ascorbic acid, azithromycin, ceftriaxone, cholecalciferol, and zinc. Patient was comfort care and expired 10/10/2021 at 1416.
Development of mild right sided Bell's Palsy 16 days after second Pfizer COVID vaccination
Excessive urination no treatment 8-16 oz every hour. Have lost 42 lbs. Bladder check, kidney ultrasound. I was fine before this.
Difficulty breathing, muscle weakness, muscle soreness, cramps, palpitations (all over) chest pain.
Very sore arm; sweats; chills and shaking; fever of 101F for over 12 hours; fatigue and muscle aches and pains.
a)Patient's Crohn's Disease is diagnosed in Aug 2005. b)Remission achieved Dec 2005. c) Typhoid short in Jan 2006 before an overseas trip caused minor flare for 3-4 days starting Jan 26. 2006( See VAERS report E-14626 ). d) Dec 1, 2006, Hepatitis A and 2 Flu shots. e) Dec 16: Crohn's Disease Flared up again. Currently disease is highly active. Follow-up: Crohn's flare-up is still active. Steroid based treatment and colonoscopy have been prescribed and carried out. Disease is highly active for past 5 months.
Overnight, roughly 12+ hours after receiving the second dose of Pfizer-BioNTech COVID19 vaccine, I experienced chills, sweating, confusion, irritability, high fever of 101.8°F, inability to sleep soundly,  discomfort and aches throughout my body.